首页> 美国卫生研究院文献>American Journal of Physiology - Renal Physiology >The full-length calcium-sensing receptor dampens the calcemic response to 1α25(OH)2 vitamin D3 in vivo independently of parathyroid hormone
【2h】

The full-length calcium-sensing receptor dampens the calcemic response to 1α25(OH)2 vitamin D3 in vivo independently of parathyroid hormone

机译:全长钙敏感受体可独立于甲状旁腺激素而抑制体内对1α25(OH)2维生素D3的钙化反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1α,25(OH)2 vitamin D3 [1,25(OH)2D3] increases serum Ca2+ concentration in vivo, an action counteracted by activation of the Ca2+-sensing receptor (CaSR), which decreases parathyroid hormone (PTH) secretion and increases renal Ca2+ excretion. Relatively little is known of the role the CaSR plays in this response through its potentially direct actions in kidney, gut, and bone independently of PTH. We report PTH-independent roles of the CaSR in modulating the response to exogenous 1,25(OH)2D3 in mice with targeted disruption of both the CaSR and PTH genes (CP) compared with that in mice with disruption of the PTH gene alone (C+P) or wild-type mice (C+P+). After intraperitoneal injection of 0.5 ng/g body wt 1,25(OH)2D3, peak calcemic responses were observed at 24 h in all three genotypes in association with 1) a greater increase in serum Ca2+ in CP mice than in the other genotypes on a Ca2+-replete diet that was attenuated by a Ca2+-deficient diet and pamidronate, 2) increased urinary Ca2+-to-creatinine ratios (UCa/Cr) in the C+P and C+P+ mice but a lowered ratio in the CP mice on a Ca2+-replete diet, and 3) no increase in calcitonin (CT) secretion in the C+P+ and C+P mice and a small increase in the CP mice. PTH deficiency had the anticipated effects on the expression of key genes involved in Ca2+ transport at baseline in the duodenum and kidney, and injection of 1,25(OH)2D3 increased gene expression 8 h later. However, the changes in the genes evaluated did not fully explain the differences in serum Ca2+ seen among the genotypes. In conclusion, mice lacking the full-length CaSR have increased sensitivity to the calcemic action of 1,25(OH)2D3 in the setting of PTH deficiency. This is principally from enhanced 1,25(OH)2D3-mediated gut Ca2+ absorption and decreased renal Ca2+ excretion, without any differences in bone-related release of Ca2+ or CT secretion among the three genotypes that could explain the differences in their calcemic responses.
机译:1α,25(OH)2维生素D3 [1,25(OH)2D3]增加体内血清Ca 2 + 的浓度,这一作用被Ca 2 + 感应受体(CaSR),可减少甲状旁腺激素(PTH)的分泌并增加肾脏Ca 2 + 的排泄。关于CaSR通过其在肾脏,肠和骨骼中的潜在直接作用而与PTH无关的潜在作用,对此的作用知之甚少。我们报道了CaSR在调节对CaSR和PTH基因的靶向破坏的小鼠中对外源1,25(OH)2D3的应答中与PTH无关的作用(C - P -< / sup>)与仅破坏PTH基因的小鼠(C + P -)或野生型小鼠(C + P + )。腹腔注射0.5 ng / g体重的1,25(OH)2D3后,所有三种基因型在24 h均观察到峰值钙血症反应,与1)血清Ca 2 + 的增加有关C - P -小鼠中的饮食比其他基因型受Ca 2 + 饮食(被Ca 2减弱)的其他基因型+ -缺乏饮食和帕米膦酸盐,2)C + P 中尿Ca 2 + -肌酐比值(UCa / Cr)增加− 和C + P + 小鼠,但C - P -小鼠的比例降低补充Ca 2 + 的饮食,并且3)C + P + 和C < sup> + P -小鼠,而C - P -小鼠略有增加。 PTH缺乏对基线时十二指肠和肾脏中参与Ca 2 + 转运的关键基因的表达具有预期的影响,注射1,25(OH)2D3在8 h后基因表达增加。然而,所评估基因的变化并不能完全解释基因型之间所见的血清Ca 2 + 的差异。总之,在PTH缺乏的情况下,缺乏全长CaSR的小鼠对1,25(OH)2D3的钙化作用的敏感性增加。这主要是由于增强的1,25(OH)2D3介导的肠道Ca 2 + 吸收和减少的肾脏Ca 2 + 排泄,而与骨相关的释放没有任何差异。三种基因型之间的Ca 2 + 或CT分泌可以解释其钙质反应的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号